Gu He

9k citations
212 papers · 7.3k · 3 hit papers · h-index 46

Impact in

Papers in

    • Asymmetric Synthesis and Catalysis 20
    • Synthesis and biological activity 18
    • Nanoparticle-Based Drug Delivery 21

Gu He

208 papers receiving 7.1k citations

Gu He's Hit Papers

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials 2023 · 273 citations
2730+2+4Years since publication100200300

Peers

Gu He
Comparison fields: 5 of 134
  • Biomaterials 706
  • Dermatology 462
  • Organic Chemistry 1.7k
  • Drug Discovery 10
  • Pharmaceutical Science 232
Replace Fengshan Wang with:
Fengshan Wang China
Pithi Chanvorachote B Thailand
Tatiana Syrovets Germany
Zhiyun Du China
Renata Kontek Poland
Frank Stahl Germany
Han Chang Kang South Korea
Dragana Nikitovic Greece
Mateusz Kciuk Poland
Mandip Singh Sachdeva United States
Gu He relative to Fengshan Wang China Fengshan Wang's profile →
Citations per field
00.5×2×4×5.3×
Fengshan Wang · 1×
Citations per year

Countries citing papers authored by Gu He

Since Specialization
Citations

This map shows the geographic impact of Gu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu He more than expected).

Fields of papers citing papers by Gu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu He. The network helps show where Gu He may publish in the future.

Co-authors

The 25 scholars most cited alongside Gu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gu He Line = papers co-authored together Gu He links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Hit paper breakdown →
2021339
2
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Hit paper breakdown →
2023273
3
From pathogenesis of acne vulgaris to anti-acne agents
Hit paper breakdown →
2019231
4 2009198
5 2017180
6 2019177
7 2016154
8 2017134
9 2022134
10 2018129
11 2023120
12 2015113
13 201496
14 201787
15 201786
16 202485
17 201083
18 201582
19 201981
20 202073

About Gu He

Gu He is a scholar working on Organic Chemistry, Biomaterials, Molecular Biology, Computational Theory and Mathematics and Dermatology, having authored 212 papers that have together received 7.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), Asymmetric Synthesis and Catalysis (20 papers), Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (17 papers), Protein Degradation and Inhibitors (11 papers), RNA Interference and Gene Delivery (11 papers), Autophagy in Disease and Therapy (9 papers) and Acne and Rosacea Treatments and Effects (6 papers). The work is most often cited by research in Biomaterials (706 citations), Dermatology (462 citations), Organic Chemistry (1.7k citations), Drug Discovery (10 citations) and Pharmaceutical Science (232 citations). Gu He has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bo Han, Cheng Yun Peng, Wei Huang, Xian Li Jiang, Xiang Wen, Lian Wang, Dan Hao, Liang Ouyang, Xiang‐Hong He and Fengbo Wu. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Chemical Communications, International Journal of Molecular Sciences and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact